Literature DB >> 18443625

Approaches to the discovery of new antibacterial agents based on bacteriocins.

Clarissa S Sit1, John C Vederas.   

Abstract

The development of antibiotic resistance in pathogenic bacteria has led to a search for novel classes of antimicrobial drugs. Bacteriocins are peptides that are naturally produced by bacteria and have considerable potential to fulfill the need for more effective bacteriocidal agents. In this mini-review, we describe research aimed at generating analogues of bacteriocins from lactic acid bacteria, with the goal of gaining a better understanding of structure-activity relationships in these peptides. In particular, we report recent findings on synthetic analogues of leucocin A, pediocin PA1, and lacticin 3147 A2, as well as on the significance of these results for the design and production of new antibiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443625     DOI: 10.1139/O07-153

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  11 in total

1.  Antifungal activity of Lactobacillus against Microsporum canis, Microsporum gypseum and Epidermophyton floccosum.

Authors:  Jiahui Guo; Brid Brosnan; Ambrose Furey; Elke Arendt; Padraigin Murphy; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2012-03-01

2.  Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity.

Authors:  Clara Roces; Ana Rodríguez; Beatriz Martínez
Journal:  Probiotics Antimicrob Proteins       Date:  2012-12       Impact factor: 4.609

Review 3.  Novel approaches for Campylobacter control in poultry.

Authors:  Jun Lin
Journal:  Foodborne Pathog Dis       Date:  2009-09       Impact factor: 3.171

Review 4.  On the physiology and pathophysiology of antimicrobial peptides.

Authors:  Roland Pálffy; Roman Gardlík; Michal Behuliak; Ludevit Kadasi; Jan Turna; Peter Celec
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

5.  Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos).

Authors:  Juan Borrero; Dag A Brede; Morten Skaugen; Dzung B Diep; Carmen Herranz; Ingolf F Nes; Luis M Cintas; Pablo E Hernández
Journal:  Appl Environ Microbiol       Date:  2010-11-05       Impact factor: 4.792

6.  Plantaricyclin A, a Novel Circular Bacteriocin Produced by Lactobacillus plantarum NI326: Purification, Characterization, and Heterologous Production.

Authors:  Juan Borrero; Eoin Kelly; Paula M O'Connor; Philip Kelleher; Colm Scully; Paul D Cotter; Jennifer Mahony; Douwe van Sinderen
Journal:  Appl Environ Microbiol       Date:  2017-12-15       Impact factor: 4.792

7.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

Review 8.  Targeting agr- and agr-Like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections.

Authors:  Brian Gray; Pamela Hall; Hattie Gresham
Journal:  Sensors (Basel)       Date:  2013-04-18       Impact factor: 3.576

9.  The wide world of ribosomally encoded bacterial peptides.

Authors:  Rebecca A Flaherty; Stefan D Freed; Shaun W Lee
Journal:  PLoS Pathog       Date:  2014-07-31       Impact factor: 6.823

10.  Engineering and characterization of human β-defensin-3 and its analogues and microcin J25 peptides against Mannheimia haemolytica and bovine neutrophils.

Authors:  Harpreet Dhingra; Kamaljit Kaur; Baljit Singh
Journal:  Vet Res       Date:  2021-06-10       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.